Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Journal of Autism and Developmental Disorders
|
April 13, 2020
Exploring Social Biomarkers in High-Functioning Adults with Autism and Asperger's Versus Healthy Controls: A Cross-Sectional Analysis
Marta Del Valle Rubido, Eric Hollander, James T McCracken, et al.
JAMA Psychiatry
|
June 22, 2017
Placebo Response and Practice Effects in Schizophrenia Cognition Trials
Richard S E Keefe, Vicki G Davis, Philip D Harvey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 8, 2012
Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers
Meret Martin-Facklam, Flavia Pizzagalli, Yun Zhou, et al.
Frontiers in Psychiatry
|
August 15, 2020
Social Anxiety in Children and Adolescents With Autism Spectrum Disorders Contribute to Impairments in Social Communication and Social Motivation
Kellen Briot, François Jean, Ali Jouni, et al.
Science Translational Medicine
|
September 30, 2011
Translating glutamate: from pathophysiology to treatment
Daniel C Javitt, Darryle Schoepp, Peter W Kalivas, et al.
Molecular Autism
|
January 6, 2022
Correction to: Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)
Anouck Amestoy, Etienne Guillaud, Giulia Bucchioni, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 14, 2017
A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder
Daniel Umbricht, Marta Del Valle Rubido, Eric Hollander, et al.
Molecular Autism
|
November 14, 2021
Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)
Anouck Amestoy, Etienne Guillaud, Giulia Bucchioni, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 7, 2016
A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder
Daniel Umbricht, Marta Del Valle Rubido, Eric Hollander, et al.
The Journal of Clinical Psychiatry
|
April 2, 2016
Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison
Nina R Schooler, Stephen R Marder, K N R Chengappa, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Journal of Autism and Developmental Disorders
|
April 13, 2020
Exploring Social Biomarkers in High-Functioning Adults with Autism and Asperger's Versus Healthy Controls: A Cross-Sectional Analysis
Marta Del Valle Rubido, Eric Hollander, James T McCracken, et al.
JAMA Psychiatry
|
June 22, 2017
Placebo Response and Practice Effects in Schizophrenia Cognition Trials
Richard S E Keefe, Vicki G Davis, Philip D Harvey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 8, 2012
Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers
Meret Martin-Facklam, Flavia Pizzagalli, Yun Zhou, et al.
Frontiers in Psychiatry
|
August 15, 2020
Social Anxiety in Children and Adolescents With Autism Spectrum Disorders Contribute to Impairments in Social Communication and Social Motivation
Kellen Briot, François Jean, Ali Jouni, et al.
Science Translational Medicine
|
September 30, 2011
Translating glutamate: from pathophysiology to treatment
Daniel C Javitt, Darryle Schoepp, Peter W Kalivas, et al.
Molecular Autism
|
January 6, 2022
Correction to: Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)
Anouck Amestoy, Etienne Guillaud, Giulia Bucchioni, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 14, 2017
A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder
Daniel Umbricht, Marta Del Valle Rubido, Eric Hollander, et al.
Molecular Autism
|
November 14, 2021
Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)
Anouck Amestoy, Etienne Guillaud, Giulia Bucchioni, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 7, 2016
A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder
Daniel Umbricht, Marta Del Valle Rubido, Eric Hollander, et al.
The Journal of Clinical Psychiatry
|
April 2, 2016
Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison
Nina R Schooler, Stephen R Marder, K N R Chengappa, et al.
Page
of 8